ÂÜÀòÂÒÂ×

Raksha Shah is a seasoned entrepreneur and executive with extensive experience in the pharmaceutical and biotech industries. As Co-Founder and COO of Lipidio Pharmaceuticals since January 2019, and President of Lipidio Pharmaceuticals Australia since November 2020, Raksha has demonstrated leadership in corporate management. In addition, Raksha is a founding member of the Private Directors Association® in Southern California and has previously served as Founder and CEO of Obsidio Therapeutics and GlyTR Therapeutics, gaining valuable insights into startup development and governance. Raksha's earlier role as COO and Director at Reliant Solutions involved comprehensive oversight of operations and financial management, while prior experience at DBxcel established a solid foundation in corporate structure and team building. Raksha holds a Bachelor of Science in Biology from the University of Portsmouth and an MBA in Marketing and Finance from Croydon College.